Progress and thinking on the management of lipids / 天津医药

ABSTRACT

Atherosclerosis is the pathological basis of coronary heart disease, ischemic stroke and peripheral vascular disease (atherosclerotic cardiovascular disease, ASCVD). Blood cholesterol levels are closely related to ASCVD. The preva-lence and mortality of cardiovascular disease are increasing in China, which is a difficult task. The lipid management goal is to reduce the risk of ASCVD. Atherogenic cholesterol-non-high-density lipoprotein cholesterol (non-HDL-C) and low-den-sity lipoprotein cholesterol (LDL-C) are used as the primary targets of therapy, which may be more appropriate for lipid man-agement setting dislipidaemia value applied to Chinese clinic. Lifestyle intervention is the basis of lipid management. Effec-tive prevention and treatment of ASCVD require the comprehensive intervention of risk factors.